Skip to main content
. 2022 Jan 1;23(1):491. doi: 10.3390/ijms23010491

Figure 4.

Figure 4

(a) Seric ALP activity 28 days post-implantation of GCs, GCsGp and GCsGp/GO 0.5% wt.% Scaffolds to mice; in vivo osteogenic profile analyses (b) mRNA expression of opn and runx2 four weeks post-implantation (statistical significance #,* p < 0.05); (c) confocal microscopy protein expression of opn (red) and runx2 (green) and cell nuclei stained in blue four weeks post-implantation.